Moomoo AI 已提取核心信息
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
据报道，Novavax Inc. [NVAX] 研发总裁菲利普·杜波夫斯基于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格、交易后持股和总价值。这些信息对于投资者了解Novavax内部活动至关重要，这可能会影响公司的股票表现。
据报道，Novavax Inc. [NVAX] 研发总裁菲利普·杜波夫斯基于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格、交易后持股和总价值。这些信息对于投资者了解Novavax内部活动至关重要，这可能会影响公司的股票表现。
有用
没用